Ionis Pharma Urges Investors to Reject the Below-the-Market Offer By Post author:Sam Post published:August 23, 2017 Post category:BioPharma August 24, 2017By Mark Terry… Source: BioSpace You Might Also Like Bay Area Rigel's CFO to Exit, Effective Dec. 31, 2017 December 14, 2017 How GlycoMimetics Defied a Hematology Biotech Pitfall While Its Peers Fell December 12, 2017 Struggling Teva Gets Another Hit, Fined for Foreign Bribes January 14, 2018
